DNMT3A mutations occur in 18–22% of all AML cases and approximately 34% of CN-AML cases [27], and they are mostly heterozygous and commonly affect a hotspot encoding arginine at codon 882 (~ 60% of AML cases). This evidence concerns the gene DNMT3A and acute myeloid leukemia.